BridgeBio Pharma, Inc.
BBIONasdaqCIK 1743881HealthcareFiscal year ends Dec 31
Reports and events: 183 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2022-04-2916:05 ET | DEF 14A | Proxy statementPeriod 2022-06-22 | 0001193125-22-133557 |
| 2022-02-2506:06 ET | 10-K | Annual reportPeriod 2021-12-31 | 0000950170-22-002030 |
| 2022-02-2407:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-051102 |
| 2021-12-2707:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-366669 |
| 2021-12-1606:41 ET | 8-K | 5.07 Shareholder vote results | 0001193125-21-358518 |
| 2021-11-1808:00 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-333214 |
| 2021-11-0817:22 ET | DEF 14A | Proxy statementPeriod 2021-12-15 | 0001193125-21-323214 |
| 2021-11-0416:21 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0000950170-21-003080 |
| 2021-11-0407:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-319331 |
| 2021-10-2606:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-307134 |
| 2021-08-2317:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-254149 |
| 2021-08-1316:48 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-246183 |
| 2021-08-0516:49 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001564590-21-041676 |
| 2021-06-2216:31 ET | 8-K | 5.07 Shareholder vote results | 0001193125-21-196269 |
| 2021-06-0107:41 ET | 8-K | 9.01 Financial statements and exhibits | 0001193125-21-177835 |
| 2021-05-1417:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-162215 |
| 2021-05-1117:07 ET | 8-K | 8.01 Other events | 0001193125-21-157729 |
| 2021-05-0616:38 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001564590-21-025064 |
| 2021-04-3017:05 ET | DEF 14A | Proxy statementPeriod 2021-06-17 | 0001193125-21-145491 |
| 2021-04-1516:55 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001193125-21-117878 |
| 2021-03-3107:35 ET | 8-K | 8.01 Other events | 0001193125-21-101373 |
| 2021-02-2606:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-058156 |
| 2021-02-2517:25 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001564590-21-008969 |
| 2021-02-1717:28 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-21-005265 |
| 2021-02-1716:16 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-046513 |
| 2021-01-2907:07 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-021591 |
| 2021-01-2616:56 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-017810 |
| 2021-01-2616:23 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-21-017733 |
| 2021-01-2609:00 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-21-017128 |
| 2021-01-2608:46 ET | 8-K | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-017108 |
| 2021-01-2016:19 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-012440 |
| 2021-01-1207:44 ET | 8-K | 8.01 Other events | 0001193125-21-006802 |
| 2021-01-0416:31 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-21-001019 |
| 2020-11-0608:36 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-20-287485 |
| 2020-11-0517:07 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001564590-20-051460 |
| 2020-11-0508:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-20-286266 |
| 2020-10-2316:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-20-275507 |
| 2020-10-1516:17 ET | SC 13D | Ownership report, active investor | 0001193125-20-270273 |
| 2020-10-0617:18 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-20-264837 |
| 2020-10-0616:45 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-20-022590 |
| 2020-10-0517:30 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-20-264026 |
| 2020-10-0517:19 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-263994 |
| 2020-09-2907:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-257161 |
| 2020-08-1117:18 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001564590-20-039358 |
| 2020-08-1108:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-20-215681 |
| 2020-06-2417:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-177774 |
| 2020-06-0816:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-20-163454 |
| 2020-06-0117:09 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-20-012844 |
| 2020-05-1419:34 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001564590-20-025197 |
| 2020-05-1316:27 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-20-141632 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 17:56 ET. Listed shows no prices and gives no investment advice.